Webinar: Be Prepared and Know the FDA’s Expectations Regarding Immunogenicity Testing – Lessons Learned

The FDA released an update to the Draft Guidance for Assay Development & Validation for Immunogenicity Testing of Therapeutic Proteins in April 2016. This on-demand webinar outlines how the April 2016 draft document is being used in FDA inspections and the FDA expectations for immunogenicity testing. Specific testing parameters and acceptance criteria will be discussed in depth in addition to 483 issued in the field of immunogenicity and what they mean.

What you will learn:

• How the Draft Guidance for Assay Development & Validation for Immunogenicity Testing of Therapeutic Proteins is being implemented
• Expectations by the FDA for immunogenicity testing and interpretation in the draft guidance
• 483 Observations recently issued and what they mean

Our Expert: George Hristopoulos, Scientific Director, Immunoassay

Please fill in the form below to view our on-demand webinar.

 

 

* - Please select a country

* - Please select a state

* - Industry is required

Your name

    * Required field

Job title

    * Required field

Company

    * Required field

Country/Region

(Select from below...) Albania Algeria American Samoa Andorra Angola Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China (Mainland) Colombia Congo Cook Islands Costa Rica Croatia Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Global Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Holy See / Vatican City Honduras Hong Kong SAR, China Hungary Iceland India Indonesia Iraq Ireland Israel Italy Ivory Coast Jamaica Japan Jordan Kazakhstan Kenya Korea Kuwait Kyrgyzstan Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mexico Micronesia Moldova Monaco Mongolia Montserrat Morocco Mozambique Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Northern Mariana Islands Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Islands Poland Portugal Puerto Rico Qatar Reunion Island Romania Russia Rwanda Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands South Africa South Georgia/South Sandwich Spain Sri Lanka St. Helena St. Kitts and Nevis St. Lucia St. Vincent and Grenadines Suriname Swaziland Sweden Switzerland Syrian Arab Republic Taiwan (Greater China) Tajikistan Tanzania Thailand Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay US Minor Outlying Islands Uzbekistan Vanuatu Venezuela Vietnam Virgin Islands (British) Virgin Islands (U.S.) Western Sahara Yemen Zambia Zimbabwe * - Country required

Email

    * Required field
    * Invalid Email

Telephone

City

*

Industry:

Please select... Analytical Services Bioanalysis Biomarker Assays Biomaterials Analysis Biosimilars Biotechnology Product Characterization Catalyst Analysis Chromatography Clinical Research Services Discovery Dose Formulation Analysis Formulation Support Analysis GLP Services GMP Services Immunochemistry Immunogenicity Assays In Vitro Efficacy In Vitro Safety Inorganic Bioanalysis Inorganic Materials Analysis Later Stage Clinical Development: Product Characterization LC-MS/MS Macromolecules Mass Spectrometry Medical Devices Method Development and Validation Organic Bioanalysis Pharmaceutical Analysis Pharmaceutical Investigation Analysis PK & TK Bioanalysis Development Polymer-Linked Drug Assays Preclinical Bioanalysis Protein Analysis Quantitative Immunoassays R&D Support Sample Analysis Sampling Services Sampling Services and Safety Measurements Structural Characterization Tissue Bioanalysis Toxicology and Regulatory Consulting *

Comments:

Yes, I would like to receive Intertek's electronic notices of news, standards changes, seminars, and general information pertinent to my title, industry, and sector.